Recent studies in desmin knockout (_/_) 
INTRODUCTION
The desmin (DES) gene provides instructions for making a protein called desmin. Desmin is found in the muscles. Within muscle fibers, desmin proteins are important to maintain the structure of sarcomeres, which are necessary for muscles to contract.
1
The desmin proteins surround rod-like structures called Z-discs that are located within the sarcomere.
2,3
Desmin connects the Z-discs to one another, linking neighboring sarcomeres and forming myofibrils, the basic unit of muscle fibers. The connection of sarcomeres to each other to form myofibrils is essential for maintaining muscle fiber strength during repeated cycles of contraction and relaxation.
4 Desmin (the main intermediate filament (IF) protein) is encoded by a single gene assigned to human chromosome 2q35 and is synthesized only in cardiac, skeletal, and smooth muscles.
5 There is only one copy of the desmin gene, which consists of nine exons and eight introns within an 8.4 kb region and encodes 470 amino acids.
6 Only one 2.2 kb desmin messenger RNA is found in human striated and smooth muscle and it is translated into a single 53 kDa protein monomer, which, in turn, assembles to form filaments of 10 nm diameter.
1
Mutations in that gene are associated with desminopathy.
7 Desmin encodes a muscle-specific class III intermediate filament. Homopolymers of that protein form a stable intracytoplasmic filamentous network connecting myofibrils to each other and to the plasma membrane.
8 Desmin links the contractile apparatus to the sarcolemma, 3 the mitochondria 9 and the nucleus.
10 Desmin is also found in cell-cell adhesion complexes as desmosomes in cardiac muscle 11 and costamers in skeletal muscles.
4,12
In accordance with its function, desmin is organized into three domains, a highly conserved α-helical core flanked by globular N-and Cterminal structures (known as the "head" and "tail" domains, respectively) ( Figure 1 ). The α-helical core maintains a seven residue (heptad) repeat pattern that guides two polypeptides to form a homopolymeric coiled-coil dimer, the elementary unit of the desmin intermediate filaments. 13 The α helical rod has interruptions at three sites, resulting in four consecutive helical segments (known as 1A, 1B, 2A, and 2B) connected by short, non helical linkers.
14,15 Almost all pathogenic desmin mutations were found in the evolutionary, highly conserved α-helical coiled-coil rod domain.
16,17
The nonhelical amino-terminal (head) and carboxy-terminal (tail) domains of intermediate filament subunit proteins are highly variable in sequence and size. 18 Although their specific role is largely unknown, the head and tail domains are sites of post-translational modifications by phosphorylation and glycosylation, regulating dynamic aspects of intermediate filament organization and structure during cell cycle and developmental programs. An interplay between desmin tail and head domains is taking place, which potentially protects the amino terminus of desmin from specific proteases.
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Figure 1: Schematic structure of the human desmin protein and updated chart of desmin mutations. Desmin protein represented with precoil domain (PCD) and a highly conserved α-helical rod of 303 amino acid residues. The α-helical rod is flanked by globular N-and Cterminal (`head' and `tail') structures 15 and is interrupted by three non-helical linkers in several places resulting in four consecutive α-helical segments, 1A, 1B, 2A and 2B, connected by short non-helical linkers. Mutations reported are identified by wild-type amino acid code/position/mutant amino acid; (mutation identified in current study is in RED). The deletion mutation identified in this study causes infantile onset of skeletal and cardiac myopathy. The known mutations associated with desminopathy are from the human mutation database (http://www.hgmd.cf.ac.uk/). 28 and are to proline, a residue considered as a "helix-breaker".
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Proline is not normally present in the desmin helical rod and is known to be a potent helix breaker; its dihedral angle is fixed at -65°, creating a kink in the protein structure. In addition, proline cannot form a hydrogen bond with the residue -4 of the helix. 30 The 
PATIENTS & METHODS

Case Selection:
Five patients from two families with healthy and consanguineous parental couples were selected for the present study. Patients were retrieved from pathological and clinical records at the Institute de Myologie (Hôpital Universitaire, Pitié-Salpêtrière, Paris). Patients included show recurrent episodes of syncope from infancy and an aggressive course of muscle wasting. The five cases were subjected to mutation screening. Blood and muscle samples were obtained after written consent in accordance to the protocols approved by the local ethic committees.
RNA Extraction and RT-PCR:
Total RNA was extracted from muscle biopsy tissue (20-25 mg) by use of RNA-PLUS extraction solution (Q Biogen, Illkirch, France). We performed reverse transcription with random hexamer primers for muscle RNA, using the Superscript kit (Life Technologies). The resulting cDNA was used as a template for PCR. The entire desmin open reading frame was PCR-amplified using primers DesFor (5-ATGCTAGCACCATGAGCCAGGC CTA-3) and DesRev (5-ATGCGGCCTCTGTCTTTAGAGCA CTTCA -3) (GenBank TM accession number L22550). The PCR products were analyzed by electrophoresis on 0.75% agarose gel. After agarose gel electrophoresis, DNA bands (1446 bp or 1424 bp) were excised, eluted, purified by QiaEx II (Q Biogen, Illkirch, France), cloned into the TA cloning vector (Invitrogen) and cycle sequenced in at least nine clones using Dye Terminator Sequencing Protocol (Applied Biosystems).
Isolation of Genomic DNAs and Desmin Exon Amplification and Sequencing:
Sequence changes identified at cDNA level were confirmed on genomic DNA by amplification and direct sequencing of the specific exons. Genomic DNAs were isolated from a skeletal muscle biopsy of the patient and from peripheral blood samples of family members and normal individuals. These DNAs served as templates for PCR amplification of exons and flanking intron segments of the desmin gene. The primer sets used were previously described by Vicart et al. 39 . The primers used for amplification of exon 6 are 6For (5-GCCTGCCAGCCCCAAAGCTTT-3) and 6Rev (5-ACAGAAATGGACCACC CAGCA-3). PCR products (361or 339 bp) were purified by Qiagen columns, sequenced and sub cloned (TA Cloning Kit, Invitrogen). Sequencing of genomic DNA and cDNA was performed according to the manufacturer's instructions (Dye Primer Sequencing, Perkin-Elmer Cetus) on an automated DNA sequencer (model 373A, Applied Biosystems).
Cloning and Mutagenesis:
Human desmin cDNA was subcloned into TA cloning vector. A deletion mutation at codon 1132-1153 of wild TA DES vector was introduced into the full-length human desmin cDNA by site-directed mutagenesis. The resulting desmin TA plasmid containing either mutant or wild-type cDNA were sub cloned into eukaryotic expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA, USA) to generate the mutant or wild type corresponding desmin expression vectors.
Cell transfection studies:
The effects caused by desmin mutations have been evaluated in three types of cells. The eukaryotic expression vectors (mutant or wildtype desmin pcDNA3.1) were transfected into SW13 cell, MCF7cells and C2C12 cells. Cells were grown in Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 10% fetal bovine serum and penicillin/streptomycin (Gibco). Cells were grown to 60% confluence, the wild-type and mutant desmin vectors were transfected into cell lines using Fugene 6 according to the manufacturer's protocol (Roche, Basel, Switzerland). At 48 h after transfection, the cells were washed three times with phosphate-buffered saline and then fixed with paraformaldehyde for 15 min at room temperature.
The cells were subsequently incubated with monoclonal antibody against human desmin (D33, Dako) for 1 h at 37°C and treated with a secondary antibody conjugated with Rhodamine (Santa Cruz, Santa Cruz, CA, USA). After washing with phosphate-buffered saline, the transfected cells were analyzed by confocal immunofluorescence microscopy.
Preparation of proteins and western blot analysis:
Frozen muscles were weighed and suspended in a 0.1 M Na/KH 2 PO 4 buffer containing 2 mM EDTA (1/20, w/v). Muscles were then minced with scissors, crushed in a frosted mortar, stirred for 15 min, and sonicated on ice.
Homogenates were then centrifuged at 15000 g for 10 min at 4 °C. The supernatants were removed and the pellet was resuspended in gel filtration buffer at a 1/20 dilution (w/v) (PBS, 6Murea, 1mM EDTA, 2mMDTTwith protease inhibitors). Both the supernatant and the resuspended pellet were then aliquoted and stored at -80 °C. Protein was also prepared from cells (MCF7) after transfection with DES expression vectors. When cells reach visual confluence, the monolayer was washed twice with ice-cold PBS and cell lysis was performed by adding 100 u of Laemmli sample buffer and scraping with a rubber policeman. Cell lysates were mixed several times to shear DNA and 25 u aliquots were heated for 5 minutes at 95°C prior to SDS-PAGE electrophoresis. The protein load was adjusted according to the method of Bradford 
Immunocytochemistry:
At least one skeletal muscle biopsy was obtained from each patient. Standard histological and histochemical staining was performed on cryostat sections according to previously described protocols 41 . Serial sections that were 5μm thick were stained with Hematoxylin and eosin or with antibodies against desmin at a dilution of 1:100 (clone D33, Dako).
38 . For secondary antibodies, fluorescein-conjugated goat antimouse IgG or rhodamineconjugated goat antimouse IgG was used. Sections were examined with Axiophot 2 fluorescence microscope.
RESULTS
Analysis of the Desmin Gene Sequences:
Mutation analysis using direct nucleotide sequencing of PCR products amplified from either Genomic DNA or cDNA revealed a novel homozygous deletion mutation (amino acids, 378-384 -Nucleotides,1132-1153) in the middle of exon 6 (GenBank ID 181539, accession M63391) of homozygous patients in contrast to normal controls. The deletion causes loss of seven amino acids and a frame shift and a premature termination signal located nine codons downstream of the deletion (figure 2), thereby leading to a truncated desmin molecule which is apparent in immunoblot analysis (Figure 7 ). This mutation resides in a part of the gene that encodes an evolutionary highly conserved 2B domain of the α-helical coiled-coil rod domain of the desmin protein. The site is known to be critically involved in filament assembly 42 and interactions with other cellular proteins 43 . The sequencing profile of the heterozygous healthy parents showed turbidity in contrast to the clear profile in homozygous patients and normal control persons (Figure 3) . The turbidity in the sequence profile is due to the presence of the two transcripts (i.e. normal and deleted) in the amplified sequenced product of the healthy heterozygous parents. 
Functional Studies:
The functional consequences of the novel desmin mutation were studied by means of transfection studies. To assess the ability of the desmin mutation to assemble into a de novo filament network, wild-type and mutant desmin expression vectors were transiently transfected into SW13 and MCF-7 cells. (Figure 5 B) . While the transfection of mutant desmin PcDNA3.1 vector produces multiple desmin-positive clumps or abnormal solid aggregates in both cell lines (Figure 5 A) . Furthermore, the mutant desmin induces collapse of the pre-existing type III IF network in cell types that express vimentin i.e. C2C12 cell lines ( Figure 5A ). This is in agreement with previous reported data by Haubold et al. 47 . Moreover, immunoblot studies revealed abnormal band of desmin. These abnormal bands of desmin, in addition to normal desmin band, suggested mutant proteins of desmin and thus mutations in the desmin gene.
Desmin immunoreactions (Fig.7A) revealed a single band corresponding in size to 53 kDa in controls and a smaller band in patients. The 3 to 4 kDa reduction in the molecular mass of mutant desmin in patients could be explained either by removal of an -28 amino acids peptide from the carboxyl terminus of the α helical rod domain (the mutation results in loss of 7 amino acids and the premature stop codon result in loss of 21 amino acids. Also, the smaller size of the fragment may be due to loss of the post-translational modification. However, the signal intensity in the insoluble fraction from patients muscle biopsy was far more intense, indicating the presence of desmin aggregates in diseased muscle (Fig.7C) 
DISCUSSION
50
Biochemical support for this became available when it was shown that the giant actin filament-binding protein, nebulin, interacts with desmin at the periphery of the Z-discs.
43
. Desmin filament assembly is a complex process that depends on the central rod domain, whereas the tail domain is believed to be important for interactions between tetramers and elongation of higher order filament structures.
30,31
Defects in the function of desmin may therefore cause fragility of the myofibrils and impair contraction. Because intermediate filaments participate in the transmission of active force, the disruption of the filamentous network by the mutant desmin impairs the force generated within the contractile filaments and weakens the sarcomere resulting in myofibrillar damage over a period of years because of the cumulative effects of mechanical stress and muscle use
51
. Desmin-related myofibrillar myopathy (OMIM #601419) is inherited as an autosomal dominant disorder. Approximately 25% of affected individuals have an affected parent, but the proportion of de novo mutations is unknown 52 . In mice that lack desmin, the histologic features in muscle specimens from these mice are very similar to those of patients with desmin myopathy, including disrupted myofibrils and streaming of Z bands
53,54
. Mutation screening analysis of the desmin gene sequences reported the identification of an autosomal recessive mutation responsible for an infantile desmin myopathy. This novel recessive deletion mutation detected in desmin gene has clinical effects only in homozygous cases. The sequencing profile of heterozygous healthy parents shows turbidity in contrast to the clear profile of homozygous patients and normal control persons (Figure 3 ). The turbidity in the sequence profile is due to the presence of two transcripts (normal and deleted) in the amplified sequenced product of the healthy heterozygous parents. The heterozygous healthy parents have both alleles and so two bands appear in the gel of amplified PCR products of the desmin gene in contrast to a single band in healthy control and patient PCR products (Figure 4 A, B) . The detected mutation resides in a part of the gene that encodes an evolutionary highly conserved 2B domain of the α-helical coiled-coil rod domain of the desmin protein. (Figure 5 B) while mutant desmin expressed in SW13 (vimentin-negative) cells produced aggregates similar to those seen in muscle-biopsy specimens (Figure 6 ). Furthermore, the mutant desmin induces collapse of the pre-existing type III IF network in cell types that express vimentin i.e C2C12 cell lines ( Figure 5A ).This is in agreement with previous reported data by Haubold et al. 47 .These functional studies provide compelling evidence that the mutation within helix 2B is deleterious to desmin filament assembly. The identification of a desmin gene deletion that functionally compromises desmin intermediate filament assembly in these patients underscores the significance of desmin gene alterations in the production of desmin-related muscle pathology in humans.
Moreover, immunoblot studies revealed a single band corresponding in size to 53 kDa in controls and a smaller band in patients. The 3 to 4 kDa reduction in the molecular mass of mutant desmin in patients could be explained either by removal of 28 amino acids peptide from the carboxyl terminus of the α helical rod domain (the mutation results in loss of 7 amino acids and the premature stop codon result in loss of 21 amino acids) or may be due to loss of the posttranslational modification. In addition to the truncated protein, the mutation change the periodicity of the amino acids in the α helical rod domain of desmin protein and this is deleterious to desmin filament assembly and function.
From the present study, it could be concluded that, this deletion mutation has a recessive negative effect on the polymerization process of desmin intermediate filaments and is the molecular event leading to the development of the infantile autosomal recessive desmin myopathy. Elucidation of the genetic basis of heritable desminopathy might provide insights into the pathogenetic mechanisms of this disease.
